Of note, a HER2 score of 3+ or 2+ was significantly more common in patients with deeply invasive EMPD that those with in situ/superficial invasive (in which tumor invasion was limited to the papillary dermis) EMPD and was correlated with numerous LN metastases (16). This evidence concerns the gene ERBB2 and extramammary Paget disease.